|
JPS5154583A
(en)
*
|
1974-11-01 |
1976-05-13 |
Kyorin Seiyaku Kk |
Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
|
|
US4097483A
(en)
*
|
1974-11-01 |
1978-06-27 |
Kyorin Pharmaceutical Co., Ltd. |
Pyrazolo 1,5-a!pyridines
|
|
US4237300A
(en)
*
|
1975-12-09 |
1980-12-02 |
Merck & Co., Inc. |
Certain 6-substituted-2-pyridinamines
|
|
JPS5968553A
(ja)
*
|
1982-10-13 |
1984-04-18 |
Automob Antipollut & Saf Res Center |
燃料タンク内蔵式燃料ポンプ
|
|
JPS6072975U
(ja)
*
|
1983-10-26 |
1985-05-22 |
ヤンマーディーゼル株式会社 |
燃料ポンプのエア抜き装置
|
|
JPH0621066B2
(ja)
*
|
1984-03-14 |
1994-03-23 |
杏林製薬株式会社 |
３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
|
|
JPS6263520A
(ja)
*
|
1985-09-14 |
1987-03-20 |
Kyorin Pharmaceut Co Ltd |
抗リウマチ剤
|
|
US4925849A
(en)
*
|
1987-06-15 |
1990-05-15 |
Fujisawa Pharmaceutical Company, Ltd. |
Pharmaceutically useful pyrazolopyridines
|
|
JPH01153633A
(ja)
*
|
1987-12-10 |
1989-06-15 |
Kyorin Pharmaceut Co Ltd |
経皮吸収製剤
|
|
EP0355234A1
(en)
*
|
1988-08-25 |
1990-02-28 |
Merrell Dow Pharmaceuticals Inc. |
Pyrazolopyridine derivatives as antiatherosclerotic and antihypercholesterolemic agents
|
|
JPH085790B2
(ja)
*
|
1988-11-11 |
1996-01-24 |
杏林製薬株式会社 |
記憶障害改善薬
|
|
JPH0256853U
(esLanguage)
*
|
1989-10-04 |
1990-04-24 |
|
|
|
JPH06166687A
(ja)
*
|
1990-07-18 |
1994-06-14 |
Senju Pharmaceut Co Ltd |
ピラゾロ〔１，５−ａ〕ピリジン化合物、その製造法および用途
|
|
SK287231B6
(sk)
|
1999-08-21 |
2010-04-07 |
Nycomed Gmbh |
Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
|
|
BR0313593A
(pt)
|
2002-08-19 |
2005-07-12 |
Pfizer Prod Inc |
Terapia de combinação para doenças hiperproliferativas
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
AU2004226353A1
(en)
|
2003-04-01 |
2004-10-14 |
Laboratoires Serono Sa |
Inhibitors of phosphodiesterases in infertility
|
|
OA13174A
(en)
|
2003-05-30 |
2006-12-13 |
Ranbaxy Lab Ltd |
Substituted pyrrole derivatives and their use as HMG-Co inhibitors.
|
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
|
AU2004292445B2
(en)
|
2003-11-21 |
2010-02-04 |
Zalicus Inc. |
Methods and reagents for the treatment of inflammatory disorders
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
WO2007054896A1
(en)
|
2005-11-08 |
2007-05-18 |
Ranbaxy Laboratories Limited |
Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
|
BRPI0618643A2
(pt)
|
2005-11-09 |
2011-09-06 |
Combinatorx Inc |
composição compreendendo um par de fármacos, composição compreendendo um corticosteróide e um imunossupressor dependente de imunofilina não-esteróide, kits e uso
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
JP5352452B2
(ja)
*
|
2006-06-06 |
2013-11-27 |
メディシノバ， インコーポレイテッド |
置換ピラゾロ［１，５−ａ］ピリジン化合物およびその使用方法
|
|
CN101663262B
(zh)
|
2006-12-01 |
2014-03-26 |
百时美施贵宝公司 |
用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
|
|
DK2131841T3
(da)
|
2007-01-30 |
2012-10-15 |
Avigen Inc |
Fremgangsmåder til behandling af akut smerte
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
US7879802B2
(en)
|
2007-06-04 |
2011-02-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US7536799B2
(en)
*
|
2007-06-07 |
2009-05-26 |
Keson Industries |
Chalk line apparatus with strategically located chalk fill opening
|
|
AU2008273050A1
(en)
*
|
2007-07-11 |
2009-01-15 |
Auckland Uniservices Limited |
Pyrazolo[1,5-a]pyridines and their use in cancer therapy
|
|
BRPI0814939A2
(pt)
*
|
2007-08-10 |
2015-01-27 |
Glaxosmithkline Llc |
Entidade química, composição farmacêutica, e, método para tratar uma infecção viral em um mamífero.
|
|
JP5263548B2
(ja)
*
|
2007-08-15 |
2013-08-14 |
杏林製薬株式会社 |
イブジラストを有効成分とする脳動脈瘤の予防、形成抑制又は治療剤
|
|
AU2009256157B2
(en)
|
2008-06-04 |
2014-12-18 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
WO2010005520A2
(en)
*
|
2008-06-30 |
2010-01-14 |
Concert Pharmaceuticals, Inc. |
2-alkyl-3-acylpyrazolo[1,5-a]pyridine derivatives
|
|
JP2011528375A
(ja)
|
2008-07-16 |
2011-11-17 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
|
CA2732520A1
(en)
*
|
2008-08-05 |
2010-02-11 |
Merck Sharp & Dohme Corp. |
Therapeutic compounds
|
|
WO2010021681A2
(en)
*
|
2008-08-18 |
2010-02-25 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions and methods for treatment of viral diseases
|
|
BR112012011237A2
(pt)
|
2009-11-13 |
2019-09-24 |
Univ Tokyo |
agente terapêutico e profilático para diabetes
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
CA3100941C
(en)
|
2011-03-01 |
2024-03-05 |
Synergy Pharmaceuticals Inc. |
Process of preparing guanylate cyclase c agonists
|
|
ES2395801B1
(es)
|
2011-06-23 |
2014-06-06 |
María Carmen PARDINA PALLEJÀ |
"pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"
|
|
CN102617579A
(zh)
*
|
2012-03-28 |
2012-08-01 |
黑龙江大学 |
一种异丁司特的制备方法
|
|
JP6499591B2
(ja)
|
2013-02-25 |
2019-04-10 |
シナジー ファーマシューティカルズ インコーポレイテッド |
結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
|
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
|
JP2016516804A
(ja)
|
2013-04-17 |
2016-06-09 |
ファイザー・インク |
心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
|
|
AU2014274812B2
(en)
|
2013-06-05 |
2018-09-27 |
Bausch Health Ireland Limited |
Ultra-pure agonists of guanylate cyclase C, method of making and using same
|
|
AU2014305843B2
(en)
|
2013-08-09 |
2019-08-29 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
CN108033959A
(zh)
*
|
2018-01-29 |
2018-05-15 |
山东省药学科学院 |
一种异丁司特的化学合成方法
|
|
AU2020209215B2
(en)
|
2019-01-18 |
2023-02-02 |
Astrazeneca Ab |
PCSK9 inhibitors and methods of use thereof
|
|
CN114340631A
(zh)
|
2019-05-21 |
2022-04-12 |
阿德利克斯股份有限公司 |
用于降低患者的血清磷酸盐的组合
|
|
CN113387947B
(zh)
*
|
2021-07-12 |
2022-07-01 |
中国科学院成都生物研究所 |
调节雌激素受体合成活性的吡唑并吡啶衍生物
|
|
GB202306663D0
(en)
|
2023-05-05 |
2023-06-21 |
Union Therapeutics As |
Combination therapy
|